Lord Vallance stated the government sees investment, innovation, and public-private partnership as crucial to UK healthcare.

Treatments targeting alpha-synuclein aggregation account for 26% of the 7MM' pipeline disease-modifying therapies for ...

Minghui Pharmaceutical has reported promising initial outcomes from its Phase I trial of MHB039A to treat patients with solid ...

Ionis has announced the design for a Phase III trial of ION582, a treatment for Angelman syndrome (AS), following discussions with the FDA.

Alcon’s session at the 2024 Veeva MedTech Summit in Amsterdam. Image Credit: Ross Law / GlobalData. Alcon decided to take a ...

Castle’s DecisionDx-Melanoma test is one of the company’s most in-demand products. Image credit: Pressmaster / Shutterstock. Castle Biosciences has released data from a multi-centre DECIDE study ...

The former health minister predicted a bright future for UK trials and outlined steps to ensure clinical research thrives.

Penumbra has developed a microprocessor with thrombus removal algorithms that, combined with audio-visual feedback, help ...

Zymeworks has dosed the first patient in its Phase I clinical trial of ZW191 aimed at treating advanced solid tumours.

The human version of ANK-101 is currently undergoing Phase I clinical trials in the US and Canada. Credit: ...

With the new funding, Research Grid plans to invest in research and development, creating more AI automation and expanding its engineering teams. Credit: Collagery / Shutterstock. Research Grid has ...

Intra-Cellular expects Caplyta to generate $665m-$685m in sales this year. Image credit: Lightspring / Shutterstock. Having raised the full-year sales guidance for Caplyta (lumateperone) a week ago, ...